(CIDRAP News) – More parents obtain medical vaccination exemptions for their kindergarten children in states where they are easier to get, which potentially reduces herd immunity and poses a threat to children who have real medical contraindications to vaccination, according to a study published yesterday in the Journal of Infectious Diseases.
(CIDRAP News) Sanofi Pasteur's intradermal influenza vaccine, which involves a shallow needle prick into the skin instead of deep into muscle tissue, has been approved by the US Food and Drug Administration (FDA), the company announced today.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) recently issued new guidance for preventing flu in healthcare settings that reflects a year's worth of new information about the 2009 H1N1 virus and recommends surgical masks rather than N-95 respirators when providing routine care for flu patients.
Editor's Note: This is the first of a series of articles reviewing the world's experience with pandemic H1N1 influenza and what we've learned in the past year. Look for further installments in the days to come.
(CIDRAP News) A year's experience with the 2009 H1N1 influenza virus has underscored the endless unpredictability of flu.
(CIDRAP News) One third of US adults aged 65 and older are not vaccinated against pneumonia, according to a national report that describes them as representative of millions of adult Americans who are vulnerable to diseases that can be forestalled by vaccines.
(CIDRAP News) Workers ages 50 to 64 who get their annual flu shots miss less work and experience less of a productivity drop-off than those who don't, according to a new study, findings that might help public officials lift immunization rates among this age-group.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.